7Baggers
Quarterly
Annual
    Unit: USD2024-06-30 2024-03-31 2023-12-31 2023-09-30 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 
      
    		          
      operating activities
    		          
      net income
    		5,804,000 5,726,000 -13,001,000 1,240,000 696,000 1,772,000 1,606,000 1,524,000 788,000 -3,666,000 
      adjustments to reconcile net income to net cash from operating activities:
    		          
      benefit from (credit to) credit losses
    		          
      depreciation
    		514,000 498,000 342,000 263,000 243,000 223,000 192,000 192,000 -21,000 253,000 
      amortization of intangible assets
    		1,204,000 1,207,000 484,000 59,000 61,000 65,000 65,000 67,000 -195,000 306,000 
      accretion of discounts
    		-2,775,000 -3,268,000 243,000 -126,000       
      origination of loans to be sold
    		-766,000 -201,000 -465,000 0 0 -5,703,000 -1,799,000 -1,860,000 0  
      proceeds from loan sales
    		778,000 251,000 496,000 0 0 6,123,000   218,000  
      gain on sale of loans
    		-12,000 -50,000 -169,000 0 0 -420,000 -153,000 -180,000 0  
      share-based and deferred compensation
    		423,000 402,000 422,000 205,000 163,000 144,000 104,000 245,000   
      bank-owned life insurance income
    		-386,000 -383,000 -250,000 -178,000 -116,000 -156,000 -115,000 -110,000 -77,000 -108,000 
      (gain) loss on sale of debt securities, available for sale
    		          
      change in accrued interest receivable and other assets
    		2,769,000 -2,046,000 -4,128,000 545,000 -2,208,000 959,000 -558,000 -1,798,000 -622,000 1,610,000 
      change in accrued interest payable and other liabilities
    		-1,154,000 -2,863,000 2,835,000 1,338,000 -231,000 646,000 130,000 -720,000 -1,092,000 2,775,000 
      other
    		-3,000 -84,000         
      net cash from operating activities
    		6,392,000 -771,000 -3,347,000 2,997,000 -2,407,000 3,948,000 3,463,000 -2,660,000 -643,000 6,021,000 
      investing activities
    		          
      investment securities available for sale:
    		          
      proceeds from sales
    		  89,517,000 0 0 0 0 513,000   
      proceeds from calls and maturities
    		1,000,000 295,000   95,000 0 400,000 750,000 1,520,000 -73,620,000 
      proceeds from principal repayments
    		3,191,000 2,357,000 2,640,000 1,886,000 2,155,000 2,477,000 3,569,000 3,702,000 5,260,000 15,606,000 
      purchases
    		-12,294,000 -22,622,000 0 0     0  
      investment securities held to maturity:
    		          
      proceeds from redemptions of certificates of deposit with other banks
    		  249,000 249,000 2,735,000 2,730,000   249,000  
      purchase of restricted investment in bank stocks
    		-3,691,000 -6,440,000 -8,762,000 -1,009,000 -3,471,000 -3,526,000 0 -999,000 -36,000 841,000 
      redemption of restricted investment in bank stocks
    		3,049,000 6,119,000 14,667,000 3,446,000 3,421,000 2,766,000 1,045,000 72,000 901,000 -2,696,000 
      increase in loans
    		  -16,350,000 -9,021,000 -62,752,000 -73,058,000 -54,842,000 -15,754,000 -49,764,000 70,149,000 
      purchase of bank-owned life insurance
    		  -4,712,000 0       
      cash paid to buy-out minority interest
    		0 -483,000         
      proceeds from disposal of premises and equipment
    		          
      purchase of premises and equipment
    		-55,000 -452,000 -489,000 -599,000 2,101,000 -1,395,000 -2,854,000 -156,000 -149,000 397,000 
      net cash from investing activities
    		-64,946,000 -20,880,000 119,342,000 -4,006,000 -57,248,000 -73,767,000 -74,703,000 -16,872,000 -35,544,000 40,562,000 
      financing activities
    		          
      increase in deposits
    		70,629,000 86,524,000 -43,166,000 6,930,000 -4,938,000 49,337,000 40,203,000 90,505,000 -30,930,000 -52,688,000 
      change in short-term borrowings
    		0 -10,000,000 -59,702,000 15,101,000 20,938,000 -1,639,000     
      proceeds from long-term borrowings
    		0 40,000,000         
      issuance of shares from exercise of stock options
    		0 11,000   0 0     
      dividends paid
    		-2,702,000 -2,845,000 -1,218,000 -1,217,000 -1,121,000 -738,000 -738,000 -737,000 -737,000  
      net proceeds from issuance of common stock
    		1,000 54,000 152,000 0 -9,000      
      net cash from financing activities
    		67,928,000 113,744,000 -103,784,000 -54,186,000 14,870,000 81,619,000 25,107,000 106,071,000 -44,767,000 1,352,000 
      increase in cash and cash equivalents
    		9,374,000 92,093,000 12,211,000 -55,195,000 -44,785,000 11,800,000 -46,133,000 86,539,000 -80,954,000 47,935,000 
      cash and cash equivalents at beginning of period
    		0 80,190,000 0 0 0 0 0 22,590,000 0 24,160,000 
      cash and cash equivalents at end of period
    		9,374,000 172,283,000 12,211,000 -55,195,000 -44,785,000 11,800,000 -46,133,000 109,129,000 -80,954,000 72,095,000 
      benefit from credit losses
    		 40,000         
      loss on sale of debt securities, available for sale
    		          
      decrease (increase) in loans
    		 213,000         
      capitalized mortgage servicing rights
    		          
      gain on sale of debt securities, available for sale
    		  0 0 0 0 0 -13,000   
      proceeds from death benefit under bank-owned life insurance
    		    0      
      purchase of computer software
    		          
      net cash acquired through merger and acquisition
    		        0  
      proceeds from issuance of subordinated debt
    		    0 0     
      (credit to) benefit from credit losses
    		   -349,000       
      proceeds from other borrowings
    		       31,969,000   
      benefit from loan losses
    		    100,000 515,000 395,000 280,000 100,000 -69,000 
      amortization of premiums and (discounts)
    		    -1,044,000 -220,000 -188,000 -495,000   
      investment securities held to maturity
    		          
      purchase of certificates of deposit with other banks
    		        0  
      repayments of other borrowings
    		       -15,666,000   
      increase in other assets
    		       208,000   
      purchase of investment securities held to maturity
    		       -5,000,000   
      redemption of bank-owned life insurance
    		          
      amortization of premiums and discounts
    		          
      repayments of long-term borrowings
    		        -13,220,000 13,108,000 
      amortization of premiums and discounts on investment securities
    		         1,147,000 
      payment of death benefit under bank-owned life insurance
    		          
      share-based compensation
    		          
      amortization of premiums on purchased loans
    		          
      deferred tax benefit
    		          
      proceeds from exercise of stock options
    		          
      supplemental cash flow disclosures
    		          
      cash paid during the period for:
    		          
      interest
    		          
      income taxes
    		          
      non-cash activities :
    		          
      right of use asset
    		          
      operating lease liability
    		          
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.